Breast
BNT327-05 (ROSETTA Breast-01)
A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC whose tumor PD-L1 status is considered negative
Trial overview
Clinical Area
Medical Oncology
Disease
Breast cancer
Disease site
Breast
Study Phase
III
Trial Identifiers
Registration number: NCT07173751
GenesisCare Location(s)
Principal Investigator(s)